New Drug Approvals and Prohibition during the Mid-Year of 2016

Authors

  • Nisha Shri C. Department of Pharmacology, T. John College of Pharmacy, Bangalore, Karnataka, India
  • Vineeth Chandy Department of Pharmacology, T. John College of Pharmacy, Bangalore, Karnataka, India
  • Preethi Shree C Department of Pharmacology, T. John College of Pharmacy, Bangalore, Karnataka, India
  • Balaji J. Department of Analytical Services, Strides Shasun Research Ltd., Bangalore, Karnataka, India

Abstract

Every day drugs are being approved by various drug controlling authorities, for treating ailments and for improvising health care. USFDA, CDER and CDSCO (Central Drugs Standard Control Organization) play major role in controlling the drug usage in India, to ensure the safety and efficacy of the treatments. In India most of the OTC products has been banned and this review helps in simplifying the list of the drugs banned and newly approved in the year 2016.

 

Keywords: Drug approval in 2016, drugs banned in 2016, Fixed dose combinations banned

Cite this Article

Nisha Shri C., Vineeth Chandy, Preethi Shree C. et al. New Drug Approvals and Prohibition during the Mid-Year of 2016. Research & Reviews: A Journal of Drug Design & Discovery. 2017; 4(1): 22–25p.

Downloads

Published

2019-03-04

Issue

Vol. 4 No. 1 (2017)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.